Literature DB >> 24151818

Dysarthria and dysphagia are highly prevalent among various types of neuromuscular diseases.

Simone Knuijt1, Johanna G Kalf, Bert J M de Swart, Gea Drost, Henk T Hendricks, Alexander C H Geurts, Baziel G M van Engelen.   

Abstract

PURPOSE: Patients with a neuromuscular disease (NMD) can present with dysarthria and/or dysphagia. Literature regarding prevalence rates of dysarthria and dysphagia is scarce. The purpose of this study was to determine prevalence rates, severity and co-presence of dysarthria and dysphagia in adult patients with NMD.
METHOD: Two groups of adult patients with NMD were included: 102 consecutive outpatients (the "unselected cohort") and 118 consecutive patients who were referred for multidisciplinary assessment (the "selected cohort"). An experienced speech-language pathologist examined each patient in detail.
RESULTS: The pooled prevalence of dysarthria was 46% (95% CI: 36.5-55.9) and 62% (95% CI: 53.3-70.8) in the unselected and selected cohorts, respectively. The pooled prevalence of dysphagia was 36% (95% CI: 27.1-45.7) and 58% (95% CI: 49.4-67.2) in the unselected and selected cohorts, respectively. There was a modest but significant association between the presence of dysarthria and dysphagia (rs = 0.40; p < 0.01). Although the dysphagia was generally mild, dysarthria was moderate to severe in 15% of the dysarthric patients.
CONCLUSION: The prevalence rates of dysarthria and dysphagia among patients with various types of NMD are high. Physicians should therefore be aware of this prevalence and consider referring NMD patients to a speech-language pathologist. IMPLICATONS OF REHABILITATION: Both dysarthria and dysphagia are highly prevalent among patients with neuromuscular diseases; moreover, although often mild, these disorders can occur relatively early in the course of the disease. Clinicians should routinely check for signs and symptoms related to dysarthria and/or dysphagia in patients who present with a neuromuscular disease, preferably using standardised instruments.

Entities:  

Keywords:  Dysarthria; dysphagia; neuromuscular diseases

Mesh:

Year:  2013        PMID: 24151818     DOI: 10.3109/09638288.2013.845255

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  7 in total

1.  European Survey: Dysphagia Management in Patients with Neuromuscular Diseases.

Authors:  Nicolas Audag; Michel Toussaint; Giuseppe Liistro; Laure Vandervelde; Emmanuelle Cugy; Gregory Reychler
Journal:  Dysphagia       Date:  2022-01-03       Impact factor: 2.733

Review 2.  Screening and evaluation tools of dysphagia in adults with neuromuscular diseases: a systematic review.

Authors:  Nicolas Audag; Christophe Goubau; Michel Toussaint; Gregory Reychler
Journal:  Ther Adv Chronic Dis       Date:  2019-01-31       Impact factor: 5.091

Review 3.  The adult multidisciplinary respiratory neuromuscular clinic.

Authors:  Neeraj M Shah; Patrick B Murphy; Georgios Kaltsakas
Journal:  Breathe (Sheff)       Date:  2020-09

4.  Towards Evaluating Pitch-Related Phonation Function in Speech Communication Using High-Density Surface Electromyography.

Authors:  Mingxing Zhu; Xin Wang; Hanjie Deng; Yuchao He; Haoshi Zhang; Zhenzhen Liu; Shixiong Chen; Mingjiang Wang; Guanglin Li
Journal:  Front Neurosci       Date:  2022-07-22       Impact factor: 5.152

Review 5.  Obtaining Objective Clinical Measures During Telehealth Evaluations of Dysarthria.

Authors:  Jordanna S Sevitz; Brianna R Kiefer; Jessica E Huber; Michelle S Troche
Journal:  Am J Speech Lang Pathol       Date:  2021-03-10       Impact factor: 2.408

6.  Dysphagia and Dysarthria in Children with Neuromuscular Diseases, a Prevalence Study.

Authors:  Mieke Kooi-van Es; Corrie E Erasmus; Bert J M de Swart; Nicoline B M Voet; Philip J van der Wees; Imelda J M de Groot; Lenie van den Engel-Hoek
Journal:  J Neuromuscul Dis       Date:  2020

7.  Swallowing, Chewing and Speaking: Frequently Impaired in Oculopharyngeal Muscular Dystrophy.

Authors:  Rosemarie H M J M Kroon; Corinne G C Horlings; Bert J M de Swart; Baziel G M van Engelen; Johanna G Kalf
Journal:  J Neuromuscul Dis       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.